|
DE3779221D1
(de)
|
1986-08-19 |
1992-06-25 |
Genentech Inc |
Einrichtung und dispersion zum intrapulmonalen eingeben von polypeptidwuchsstoffen und -zytokinen.
|
|
JPH01215289A
(ja)
|
1988-02-22 |
1989-08-29 |
Toa Nenryo Kogyo Kk |
遺伝子組換えによる正常ヒト血清アルブミンａの製造方法
|
|
FR2649991B2
(fr)
|
1988-08-05 |
1994-03-04 |
Rhone Poulenc Sante |
Utilisation de derives stables du plasmide pkd1 pour l'expression et la secretion de proteines heterologues dans les levures du genre kluyveromyces
|
|
US5728553A
(en)
|
1992-09-23 |
1998-03-17 |
Delta Biotechnology Limited |
High purity albumin and method of producing
|
|
WO1995031479A1
(en)
|
1994-05-18 |
1995-11-23 |
Inhale Therapeutic Systems, Inc. |
Methods and compositions for the dry powder formulation of interferons
|
|
DE4417598A1
(de)
|
1994-05-19 |
1995-12-14 |
Max Planck Gesellschaft |
Verwendung des Tetracyclinpromotors zur stringent regulierten Produktion von rekombinanten Proteinen in prokaryontischen Zellen
|
|
AU5132096A
(en)
|
1995-01-30 |
1996-08-21 |
Terrapin Technologies, Inc. |
Glubodies - multiplicities of proteins capable of binding a variety of small molecules
|
|
US5908621A
(en)
|
1995-11-02 |
1999-06-01 |
Schering Corporation |
Polyethylene glycol modified interferon therapy
|
|
US6620413B1
(en)
|
1995-12-27 |
2003-09-16 |
Genentech, Inc. |
OB protein-polymer chimeras
|
|
DE19641876B4
(de)
|
1996-10-10 |
2011-09-29 |
Iba Gmbh |
Streptavidinmuteine
|
|
WO1998016873A1
(en)
|
1996-10-14 |
1998-04-23 |
Firm Forsat Ltd. |
Method for preparing dispersions of chromogenic components
|
|
DE19742706B4
(de)
|
1997-09-26 |
2013-07-25 |
Pieris Proteolab Ag |
Lipocalinmuteine
|
|
GB9722131D0
(en)
|
1997-10-20 |
1997-12-17 |
Medical Res Council |
Method
|
|
CA2233725A1
(en)
|
1998-03-31 |
1999-09-30 |
Hemosol Inc. |
Hemoglobin-hydroxyethyl starch complexes
|
|
TR200003635T2
(tr)
|
1998-06-08 |
2001-04-20 |
F.Hoffmann-La Roche Ag |
Peg-IFN-ALFA ve ribavirinin kronik hepatit C tedavisinde kullanılması.
|
|
US6403564B1
(en)
|
1998-10-16 |
2002-06-11 |
Schering Corporation |
Ribavirin-interferon alfa combination therapy for eradicating detectable HCV-RNA in patients having chronic hepatitis C infection
|
|
DE19926068C1
(de)
|
1999-06-08 |
2001-01-11 |
Arne Skerra |
Muteine des Bilin-Bindungsproteins
|
|
CA2440582A1
(en)
|
2001-03-09 |
2002-10-03 |
Dyax Corp. |
Serum albumin binding moieties
|
|
WO2003029462A1
(en)
|
2001-09-27 |
2003-04-10 |
Pieris Proteolab Ag |
Muteins of human neutrophil gelatinase-associated lipocalin and related proteins
|
|
EP1430136A1
(en)
|
2001-09-27 |
2004-06-23 |
Pieris ProteoLab AG |
Muteins of apolipoprotein d
|
|
AU2003264100A1
(en)
|
2003-08-25 |
2005-03-10 |
Pieris Proteolab Ag |
Muteins of a bilin-binding protein with affinity for a given target
|
|
AU2003275958A1
(en)
|
2003-08-25 |
2005-03-10 |
Pieris Proteolab Ag |
Muteins of tear lipocalin
|
|
JP2007284351A
(ja)
|
2004-07-27 |
2007-11-01 |
Osaka Bioscience Institute |
アミロイド蛋白質の凝集を抑制する物質とその作用
|
|
EP2899277A1
(en)
|
2004-11-26 |
2015-07-29 |
Pieris AG |
Compound with affinity for the cytotoxic T lymphocyte-associated antigen (CTLA-4)
|
|
JP2009509535A
(ja)
|
2005-09-27 |
2009-03-12 |
アムニクス， インコーポレイテッド |
タンパク様薬剤およびその使用
|
|
JP5848006B2
(ja)
|
2007-10-19 |
2016-01-27 |
アボット・ラボラトリーズＡｂｂｏｔｔ Ｌａｂｏｒａｔｏｒｉｅｓ |
Ｎｇａｌの検出用イムノアッセイ及びキット
|
|
CA2729322C
(en)
|
2008-06-24 |
2020-05-26 |
Technische Universitaet Muenchen |
Muteins of hngal and related proteins with affinity for a given target
|
|
WO2010054025A1
(en)
*
|
2008-11-05 |
2010-05-14 |
Abbott Laboratories |
Neutrophil gelatinase-associated lipocalin (ngal) protein isoforms enriched from urine and recombinant chinese hamster ovary (cho) cells and related compositions, antibodies, and methods of enrichment, analysis and use
|
|
EP3660510A3
(en)
|
2009-12-07 |
2020-07-08 |
Pieris Pharmaceuticals GmbH |
Muteins of human lipocalin 2 (lcn2, hngal) with affinity for a given target
|
|
US8986951B2
(en)
*
|
2010-06-08 |
2015-03-24 |
Pieris Ag |
Tear lipocalin in muteins binding IL-4 R alpha
|
|
CA2808392C
(en)
|
2010-08-16 |
2020-03-10 |
Pieris Pharmaceuticals Gmbh |
Binding proteins for hepcidin
|
|
EP2640740B1
(en)
|
2010-11-15 |
2017-03-15 |
Pieris Pharmaceuticals GmbH |
Muteins of human lipocalin 2 with affinity for glypican-3 (gpc3)
|
|
EP3662932B1
(en)
*
|
2011-05-20 |
2021-04-07 |
H. Lundbeck A/S |
Anti-cgrp compositions and use thereof
|
|
WO2014081980A2
(en)
*
|
2012-11-21 |
2014-05-30 |
The Trustees Of Columbia University In The City Of New York |
Mutant ngal proteins and uses thereof
|
|
CA2891557A1
(en)
*
|
2013-03-26 |
2014-05-22 |
Pieris Ag |
Novel specific-binding polypeptides and uses thereof
|
|
HRP20240159T1
(hr)
*
|
2014-03-21 |
2024-04-12 |
Teva Pharmaceuticals International Gmbh |
Antagonistička protutijela usmjerena protiv peptida povezanog s genom kalcitonina i postupci koji ih koriste
|
|
US10556945B2
(en)
*
|
2014-03-21 |
2020-02-11 |
Teva Pharmaceuticals International Gmbh |
Antagonist antibodies directed against calcitonin gene-related peptide and methods using same
|
|
WO2015176017A1
(en)
*
|
2014-05-16 |
2015-11-19 |
Salk Institute For Biological Studies |
Compositions and methods for treating metabolic disorders
|
|
AU2016212087B2
(en)
|
2015-01-28 |
2019-11-07 |
Pieris Pharmaceuticals Gmbh |
Novel proteins specific for angiogenesis
|
|
BR112017017530A2
(pt)
|
2015-02-18 |
2018-04-17 |
Sanofi |
proteínas específicas para pioverdina e pioquelina
|
|
RU2736312C2
(ru)
|
2015-05-04 |
2020-11-13 |
ПИЕРИС ФАРМАСЬЮТИКАЛС ГмбХ |
Белки, специфичные в отношении cd137
|
|
US10273275B2
(en)
|
2015-05-18 |
2019-04-30 |
Pieris Pharmaceuticals Gmbh |
Muteins of human lipocalin 2 with affinity for glypican-3 (GPC3) and methods of use thereof
|
|
TW201725212A
(zh)
|
2015-12-10 |
2017-07-16 |
第一三共股份有限公司 |
特異性於降鈣素基因相關胜肽的新穎蛋白
|